Medpace Holdings, Inc. (NAS: MEDP) Stock Analysis & Fundamentals | ScreenerHero

Create free account

MEDPMedpace Holdings, Inc.

NAS · US · Healthcare · Diagnostics & Research · medpace.com

537.92USD+1.64%Mkt Cap: 15.36B $P/E: 33.871d ago

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting…

Industry Peers

Diagnostics & Research

Thermo Fisher Scientific Inc.

$201.86BUSDP/E 29.8

Danaher Corporation

$145.10BUSDP/E 39.7

$45.85BUSDP/E 44.2

IDEXX Laboratories, Inc.

$45.44BUSDP/E 42.4

Agilent Technologies, Inc.

$38.44BUSDP/E 27.3

Waters Corporation

$37.13BUSDP/E 48.1

IQVIA Holdings Inc.

$35.13BUSDP/E 26.2

$28.78BUSDP/E 34.6

Mettler-Toledo International Inc.

$26.98BUSDP/E 31.4

Quest Diagnostics Incorporated

$23.18BUSDP/E 23.1

Labcorp Holdings Inc.

$23.12BUSDP/E 25.0

Guardant Health, Inc.

Eurofins Scientific SE

$13.06BUSDP/E 27.3

$12.46BUSDP/E 53.7

Charles River Laboratories International, Inc.

bioMérieux S.A.

$9.26BUSDP/E 21.6

BillionToOne, Inc.

$5.90BUSDP/E 237.4

Twist Bioscience Corporation

Sotera Health Company

$5.21BUSDP/E 44.6

$4.73BUSDP/E 54.8

DiaSorin S.p.A.

$3.75BUSDP/E 26.5

Adaptive Biotechnologies Corporation

NeoGenomics, Inc.

GeneDx Holdings Corp.

Vimian Group AB (publ)

$1.64BUSDP/E 41.7

Personalis, Inc.

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Clínica Baviera, S.A.

$1.02BUSDP/E 21.4

OPKO Health, Inc.

Castle Biosciences, Inc.

$616.40MUSDP/E 40.2

Myriad Genetics, Inc.

Fulgent Genetics, Inc.

$293.12MUSDP/E 2.9

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Scope Fluidics S.A.

Eurofins-Cerep SA

$89.37MUSDP/E 17.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

Proteome Sciences plc

ENDRA Life Sciences Inc.

Oxford BioDynamics Plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Leveljump Healthcare Corp.

Prostatype Genomics AB (publ)

Telo Genomics Corp.

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap15.36B $

Enterprise Value14.61B $

Revenue (TTM)2.68B $

Gross Profit760.62M $

Net Income (TTM)451.12M $

Revenue/Share94.44 USD

Last Price537.92 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees6.3K

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISINUS58506Q1094

Valuation

P/E (Trailing)33.87

P/E (Forward)28.69

PEG3.30

EV/EBITDA24.72

EV/Revenue5.45

P/S5.74

P/B25.68

EPS (TTM)15.88

EPS (Forward)18.75

52W Range

306.7072% of range628.92

52W High628.92 USD

52W Low306.70 USD

Profitability

Gross Margin30.06%

Oper. Margin20.03%

EBITDA Margin22.07%

Profit Margin17.83%

ROE98.27%

ROA22.84%

Growth

Revenue Growth26.50%

Earnings Growth16.60%

Cash Flow & Leverage

Operating CF713.22M $

CapEx (TTM)31.36M $

FCF Margin18.32%

FCF Yield3.19%

Net Debt-506.59M $

Net Debt/EBITDA-0.86

Balance Sheet

Debt/Equity0.25

Current Ratio0.85

Quick Ratio0.78

Book Value/Sh20.95 USD

Cash/Share22.85 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating2.9 (Hold)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)472.33 USD

Upside (mean)-12.2%

Target Range329.00 USD – 586.00 USD

$329.00-12.2% to mean$586.00

# Analysts12

Ownership

Shares Out.28.56M

Float23.00M

Insiders19.43%

Institutions87.10%

Short Interest

Short Ratio6.9d

Short % Float9.23%

Short % Out.7.44%

Shares Short2.13M

Short (prev mo.)2.05M

Technical

SMA 50470.14 (+14.4%)

SMA 200515.51 (+4.3%)

Beta1.15

S&P 52W Chg20.25%

Avg Vol (30d)289.31K

Avg Vol (10d)302.84K

Technical Indicators

RSI (14)62.3

MACD19.8913

MACD Signal21.9137

MACD Hist.-2.0224

BB Upper588.06 USD

BB Middle517.60 USD

BB Lower447.14 USD

BB Width27.23%

ATR (14)17.65 USD

Vol Ratio (20d)0.82x